EPR Alert! Unregistered Producers In Colorado No Longer Permitted To Sell 1 July

Packaging producers subject to Colorado’s Extended Producer Responsibility program that have not registered with the organization running the program will no longer be able to sell in the state starting 1 July.

Police light
(Shutterstock)

Personal care companies subject to Colorado’s Extended Producer Responsibility program that are not yet registered with the Approved Responsibility Organization (PRO) managing the program will no longer be permitted to sell or distribute products in the state starting 1 July.

That date is also the deadline by which producers in Minnesota must register with the PRO, Circular Action Alliance, and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Policy & Regulation

Producers Sue Oregon Over ‘Crushing’ EPR Recycling Law, Call It Unconstitutional

 

A national wholesalers’ trade group is suing Oregon, claiming its EPR law, which requires producers to register, report packaging data and pay fees, is unconstitutional and overly burdensome.

Senate HELP Committee Adds Sunscreen Regulation Overhaul To OMUFA Reauthorization

 
• By 

OMUFA reauthorization bill including amendment with sunscreen regulation provisions passed by Senate committee, which also approved other provisions not included in House OMUFA bill.

Sunscreen Regulation Reforms Still Could Hitch Ride On Senate OMUFA Reauthorization Bill

As stakeholders and lawmakers pin their hopes on OMUFA reauthorization as a vehicle for enacting sunscreen regulatory changes, Senate version of the bill could be the ticket after a sunscreen-specific amendment withdrawn in the House.

Unanimous Support Across House Energy And Commerce To Reauthorize FDA’s OMUFA Program

 

Committee voted 51-0 to approve five-year authorization of FDA program user fee program needed to support regulatory pathway for large majority of nonprescription drugs available in the US with amendment to expand stakeholder engagement with FDA.

More from HBW Insight

NIVEA’s ‘Milestone’ Launch Brings ‘Breakthrough’ Anti-Aging Tech To Masses

 

Beiersdorf is launching NIVEA Epigenetics Rejuvenating Serum with Epicelline, the biggest launch in its history. The range will debut first in Europe, reaching 30 countries by the end of 2025.

Repeat Buyers Passing 50% Key For Opill Sales Leading Perrigo’s Women’s Health Growth

 

“We continue to grow the brand. It was slower than initially anticipated or forecasted in basis, but I'm pleased with how it's developing,” says CEO Patrick Lockwood-Taylor of Opill performance.

UK’s ProBiotix Health Launches Menopause And Post-Menopause Supplements

 
• By 

YourBiotixMH and YourBiotixPMH “offer unique multi-positioning functionality, targeting not only cardiovascular health but also addressing key health risks associated with menopause and post-menopause, including mood imbalances, psychological challenges and bone loss,” according to ProBiotix Health.